Allos Therapeutics (ALTH) Tops Q3 EPS by 3c
Tweet Send to a Friend
Allos Therapeutics (Nasdaq: ALTH) reports a Q3 loss of $0.18, 3 cents better than the analyst estimate of ($0.21) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
